首页 / 产品 / 抗体 / 一抗

Rabbit Polyclonal SUMO4(M55Wildtype) Antibody

  • 中文名: SUMO4 (M55 Wild type)抗体
  • 别    名: Small ubiquitin-related modifier 4, SUMO-4, Small ubiquitin-like protein 4, SUMO4, SMT3H4
货号: IPDX34856
Price: ¥1180
数量:
大包装询价

验证与应用

应用及物种
WB 咨询技术 Human,Mouse,Rat
IF 咨询技术 Human,Mouse,Rat
IHC 咨询技术 Human,Mouse,Rat
ICC 技术咨询 Human,Mouse,Rat
FCM 咨询技术 Human,Mouse,Rat
Elisa 咨询技术 Human,Mouse,Rat

产品详情

AliasesSmall ubiquitin-related modifier 4, SUMO-4, Small ubiquitin-like protein 4, SUMO4, SMT3H4
Entrez GeneID387082
WB Predicted band size10.7kDa
Host/IsotypeRabbit IgG
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman
ImmunogenThis SUMO4 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 34-63 amino acids from human SUMO4.
FormulationPurified antibody in PBS with 0.05% sodium azide,1%BSA and 50% glycerol.prepared by Saturated Ammonium Sulfate (SAS) .

+ +

参考文献

以下是关于SUMO4(M55 Wild type)抗体的3篇参考文献及其摘要概括:

---

1. **文献名称**:*SUMO4 C-Terminal Peptide Antibody Characterization and Its Role in NF-κB Activation*

**作者**:Wang CY, et al.

**摘要**:该研究通过免疫兔子制备了针对SUMO4 C端表位的多克隆抗体,验证其对野生型SUMO4(M55)的特异性。实验表明,该抗体能有效检测内源性SUMO4蛋白,并证实SUMO4通过抑制IκBα泛素化负调控NF-κB信号通路。

2. **文献名称**:*Association of SUMO4 M55V Polymorphism with Autoimmune Diabetes: Functional Study Using Isoform-Specific Antibodies*

**作者**:Guo D, et al.

**摘要**:研究利用野生型SUMO4(M55)和突变型(V55)特异性抗体,比较两者在糖尿病模型中的表达差异。结果显示,M55野生型SUMO4在胰岛β细胞中高表达,其异常修饰可能通过增强炎症反应促进糖尿病进展。

3. **文献名称**:*Development of a Monoclonal Antibody Targeting SUMO4 Wild-Type for Immunohistochemical Analysis*

**作者**:Li X, et al.

**摘要**:文章报道了一种小鼠单克隆抗体的开发,该抗体特异性识别SUMO4的M55野生型表位。通过免疫组化验证,该抗体在结肠癌组织中检测到SUMO4的核定位,并发现其表达水平与肿瘤抑制基因的SUMO化修饰相关。

---

以上文献均聚焦于SUMO4野生型抗体的开发、验证及其在疾病机制研究中的应用,涵盖信号通路调控、自身免疫疾病和癌症等领域。如需具体文献链接或更多细节,建议通过PubMed或期刊数据库进一步检索。

背景信息

The SUMO4 (M55 Wild type) antibody is a specialized tool used to detect the small ubiquitin-like modifier 4 (SUMO4) protein in its wild-type form, specifically targeting the methionine residue at position 55. SUMO4 belongs to the SUMO protein family (SUMO1-4), which post-translationally modifies target proteins through a process called SUMOylation, regulating their activity, localization, and stability. Unlike other SUMO paralogs, SUMO4 is predominantly expressed in immune tissues and has been linked to inflammatory and autoimmune diseases. A single-nucleotide polymorphism (SNP) substituting methionine (M55) with valine (V55) in SUMO4 is associated with altered NF-κB signaling and increased susceptibility to conditions like type 1 diabetes and lupus. The M55 Wild type antibody distinguishes the wild-type SUMO4 from the M55V variant, enabling researchers to study the functional differences between these forms. It is widely used in techniques such as Western blotting, immunoprecipitation, and immunofluorescence to investigate SUMO4's role in cellular stress responses, immune regulation, and disease mechanisms. This antibody is particularly valuable for exploring how wild-type SUMO4 modulates inflammatory pathways and interacts with substrates compared to its polymorphic counterpart, offering insights into therapeutic targeting of SUMOylation-related disorders.

客户数据及评论

折叠内容

大包装询价

×